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Abstract Many recombinant proteins have been success-
fully produced in silkworm larvae or pupae and used for
academic and industrial purposes. Several recombinant
proteins produced by silkworms have already been com-
mercialized. However, construction of a recombinant
baculovirus containing a gene of interest requires tedious
and troublesome steps and takes a long time (3–6 months).
The recent development of a bacmid, Escherichia coli and
Bombyx mori shuttle vector, has eliminated the conven-
tional tedious procedures required to identify and isolate
recombinant viruses. Several technical improvements,
including a cysteine protease or chitinase deletion bacmid
and chaperone-assisted expression and coexpression, have
led to significantly increased protein yields and reduced
costs for large-scale production. Terminal N-acetyl glucos-
amine and galactose residues were found in the N-glycan
structures produced by silkworms, which are different from
those generated by insect cells. Genomic elucidation of
silkworm has opened a new chapter in utilization of
silkworm. Transgenic silkworm technology provides a
stable production of recombinant protein. Baculovirus
surface display expression is one of the low-cost
approaches toward silkworm larvae-derived recombinant
subunit vaccines. The expression of pharmaceutically
relevant proteins, including cell/viral surface proteins,
membrane proteins, and guanine nucleotide-binding protein
(G protein) coupled receptors, using silkworm larvae or
cocoons has become very attractive. Silkworm biotechnol-
ogy is an innovative and easy approach to achieve high
protein expression levels and is a very promising platform
technology in the field of life science. Like the “Silkroad,”
we expect that the “Bioroad” from Asia to Europe will be
established by the silkworm expression system.
Keywords Silkworm.Bombyx mori nucleopolyhedrovirus
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Introduction
Various systems to produce recombinant proteins are
available. Bacteria, especially Escherichia coli, are usually
chosen first, due to the abundance of tools available for
gene manipulations and the simple process for protein
production. However, bacteria are severely limited because
of their poor capacity to modify expressed proteins
cotranslationally and posttranslationally, in spite of recent
improvements of strains. Yeasts have some advantages over
bacteria. Recombinant proteins expressed in yeast can be
glycosylated, but certain modifications are not possible,
especially in the case of complex form of N-glycosylation.
Insect cell systems are now popular and used widely to
produce proteins from higher eukaryotes because insect
cells have a similar pattern and capacity of cotranslational
and posttranslational modifications as mammalian cells,
including glycosylation, phosphorylation, and protein pro-
cessing. The insect cell systems include the baculovirus
expression system and the stably transformed cell system.
In the baculovirus expression system, not only cultured
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protein production.
The silkworm, Bombyx mori, has been used for silk
production for centuries and recently also for protein
production, as a bioreactor. Since Maeda et al. (1985)
reported the production of human α-interferon in silkworm
larvae, using recombinant B. mori nucleopolyhedrovirus
(BmNPV), the production of many proteins has been
achieved. TORAY Ind. Inc. (Tokyo, Japan) used silkworms
to produce two recombinant proteins for veterinary use.
Intercat, a drug principally composed of feline interferon,
for feline calicivirus infections (commonly known as “cat
flu”) was introduced in February 1994 as the world’s first
antiviral drug for animal use. Interdog, a drug principally
composed of canine interferon-γ for canine atopic derma-
titis, was launched in December 2005. Nowadays, recom-
binant proteins produced from silkworms are being
investigated for commercial purposes.
This review provides an overview of the production of
recombinant proteins using silkworm larvae and pupae and
the improvement of silkworm expression systems by the
development of the BmNPV bacmid.
Silkworm genome sequence
Silkworms are the larvae of the silk moth, B. mori. B. mori
was domesticated from its wild ancestor, Bombyx mandar-
ina, and has been used for silk production for about
5,000 years. Silkworm silk in the natural form consists of
silk fibroin, the core filaments, and silk sericin, a coating
protein surrounding fibroin. Sericin is removed in commer-
cial silk, and this silk has been used in textile production for
centuries.
B. mori is an important model organism of Lepidoptera
in the fields of genetics, physiology, and biochemistry. Two
whole-genome shotgun (WGS) sequencing projects for B.
mori were reported in 2004 (Mita et al. 2004; Xia et al.
2004), and its expressed sequence tag database was
constructed (Mita et al. 2003). In 2008, two data sets from
WGS projects were merged and assembled with new data
(International Silkworm Genome Consortium 2008). The
silkworm has 28 chromosomes and an estimated genome
size of around 500 Mb. A large number of transposable
elements (TEs) exist in the B. mori genome, accounting for
43.5% of the whole. TEs occupy from 2.7% to 25% in the
whole genome in 12 Drosophila species and 47% in Aedes
aegypti (Mita et al. 2004). The gene-finder algorithm BGF
(BGI GeneFinder) predicted that approximately 18,510
genes are encoded in the silkworm genome. This gene
number in the silkworm genome is higher than that in
Drosophila melanogaster (13,379 genes), which belongs to
Diptera (Drosophila 12 Genome Consortium 2007; Nene
et al. 2007; International Silkworm Genome Consortium
2008). Moreover, orthology relationship of genes from B.
mori, D. melanogaster, A. aegypti, and Caenorhabditis
elegans by phylogenetic methods showed 13,450 gene
families. Approximately 11.45% and 25.9% of the gene
families are specific to insects and vertebrates, respectively,
and 3,223 genes are silkworm specific (The International
Silkworm Genome Consortium 2008). A genome-wide
microarray analysis of fifth-instar larvae of the silkworm
identified tissue- and developmental-stage-specific genes
(Xia et al. 2007). Tissue-specific genes and genes differen-
tially expressed in different tissues were identified. More-
over, to construct the secondary protein database of the
silkworm, proteomic identification of protein-coding genes
was performed by tandem mass spectrometry, using
silkworm pupae as the sample (Zhang et al. 2009).
Baculovirus expression system in silkworm larvae
or pupae
Silkworm larvae have been used as a bioreactor for
recombinant protein production for decades. Maeda et al.
(1985) first reported the production of human interferon
alpha (IFN-α) in the hemolymph of silkworm larvae using
BmNPV, containing the gene encoding human α-interferon
driven by the polyhedrin promoter. Recombinant proteins
expressed in silkworm larvae are shown in Table 1. Many
proteins from eukaryotes were expressed in silkworm
larvae and purified. In general, the expression level of
recombinant proteins in silkworm larvae is higher than that
in cultures cells from insect and animals. The mouse
interleukin-3 activity in the hemolymph of silkworm larvae
was about 20-fold and 10,000-fold higher than those in the
culture supernatants of BmN cells and COS7 cells,
respectively (Miyajima et al. 1987). The hemolymph of
infected silkworms showed human butyrylcholinesterase
activities 23- and 280-fold higher than those in BmN cells
and Chinese hamster ovary (CHO) cells, respectively (Wei
et al. 2000). One milligram of purified human macrophage
colony-stimulating factor (CSF) was obtained from the
hemolymph of ten silkworm larvae, and 160 μg of human
growth factor was purified from 1 ml of hemolymph
(Kadono-Okuda et al. 1995; Qiu et al. 1994).
The degradation of the expressed proteins is often
observed in silkworm larvae. This is probably caused by a
baculovirus cysteine protease, v-cath, in the baculovirus-
insect cell expression system (Kadono-Okuda et al. 1995).
To overcome this problem, BmNPV lacking the cysteine
protease gene (BmNPV-CP
−) was constructed by cotrans-
fection with BmNPV genome DNA and pBmFCPdLZ
containing the cysteine protease gene partially substituted
with the β-galactosidase gene fused with the hsp70
460 Appl Microbiol Biotechnol (2010) 85:459–470promoter. Efficient production of undegraded firefly lucif-
erase was achieved (Suzuki et al. 1997). Using this
BmNPV-CP
− strain, 4.6 mg of bovine interferon-τ was
purified from the hemolymph of 100 silkworm larvae
(Nagaya et al. 2004). This expression level is at least
tenfold higher than those of other expression systems.
Moreover, insect-derived cellulose was expressed using
BmNPV in which the cysteine protease and chitinase genes
(BmNPV-CP
−-Chi
−) were deleted, to suppress larvae
liquefaction caused by baculovirus infection (Lee et al.
2006).
Several rounds of virus amplification steps are needed for
BmNPV because the virus titer from B. mori cells is lower
than that of Sf-9 cells, and it is more difficult to obtain a high
titer of BmNPV than Autographa californica multiple
nucleopolyhedrovirus (AcMNPV), which is generally used
in the baculovirus expression system. To amplify BmNPV
rapidly, a hybrid virus of AcMNPV and BmNPV was
isolated and applied to the expression of recombinant
proteins in silkworm larvae (Mori et al. 1992). A BmScH
DNA fragment, the 572-bp SacI–HindIII fragment of the
DNA helicase gene from BmNPV, determines the host
specificity of BmNPV, and AcMNPV with the recombinant
BmScH DNA fragment from BmNPV can infect BmN cells
(Maeda et al. 1993). Two adjacent nucleotides (A and T) are
the minimal essential sequence necessary to expand the host
range of AcMNPV (Kamita and Maeda 1997). Muneta et al.
(2004) reported that 500 μg of bovine interleukin-21 (IL-21)
was purified from 30 ml of hemolymph using a hybrid
baculovirus. Silkworm pupae have also been used as a
bioreactor for recombinant protein production. Pupae can
survive at 4°C for a long time and do not require mulberry
leaves or an artificial diet during their growth. Human
granulocyte macrophage colony-stimulating factor (hGM-
CSF) was produced in pupae and purified from a homoge-
nate (Chen et al. 2006). The hGM-CSF expressed in pupae
Table 1 Expression of recombinant proteins in silkworm larvae and pupae
Proteins Used viruses or bacmids Expression level References
Intracellular protein
Firefly luciferase BmNPV 13 mg per larva Palhan et al. (1995)
Secretory proteins
Human interferon-α BmNPV 50 mg in hemolymph Maeda et al. (1985)
Human macrophage
colony-stimulating factor
BmNPV 1 mg/10 larvae (after purification) Qiu et al. (1994)
Human growth factor BmNPV 160 μg/ml hemolymph (after purification) Kadono-Okuda et al. (1995)
Rat interleukin-5 Cysteine protease depleted BmNPV 1 mg/ml hemolymph 51 mg/4 larvae
(after purification)
Ishihara et al. (1999)
Human butyrylcholinesterase BmNPV 35 μg/ml hemolymph Wei et al. (2000)
Bovine interleukin-21 HyNPV 50 μg/ml hemolymph Muneta et al. (2004)
Bovine interferon-t Cysteine protease depleted BmNPV 4.6 mg/100 larvae (after purification) Nagaya et al. (2004)
Porcine lactoferrin HyNPV 20.5 mg/100 pupae (after purification) Wang et al. (2005)
Human granulocyte
macrophage colony-
stimulating factor
BmNPV 100 μg per pupa Chen et al. (2006)
GFPuv-β3GnT2
fusion protein
BmNPV bacmid 91 μg/ml hemolymph Park et al. (2007)
EGFP-spider dragline silk
fusion protein
BmNPV bacmid 6 mg/a larva Zhang et al. (2008)
Cholera toxin B BmNPV 54.4 μg/ml hemolymph Gong et al. (2005)
Human stem cell factor BmNPV 3 μg/ml hemolymph Han et al. (2004)
anti-BSA scFV Cysteine protease and chitinase
depleted BmNPV
188 μg/ml hemolymph Ishikiriyama et al. (2009)
Human anti-BSA IgG1 Cysteine protease and chitinase
depleted BmNPV
36 μg per larva Park et al. (2009)
Human α2,6-sialyltransferase Cysteine protease and chitinase
depleted BmNPV
2.2 mg/11 larvae (after purification) Ogata et al. (2009b)
Transmembrane proteins
Human (pro)renin receptor Cysteine protease depleted BmNPV 31 μg per larva (after purification) Du et al. (2008)
Human prorenin-(pro)renin
receptor complex
Cysteine protease depleted BmNPV 70 μg/15 larvae (after purification) Du et al. (2009b)
Appl Microbiol Biotechnol (2010) 85:459–470 461had a molecular mass of 29 kDa, which is greater than that
produced in the hemolymph of silkworm larvae. Moreover,
the hGM-CSF expressed in pupae was glycosylated without
its signal peptide. These results suggest that some comodi-
fication and postmodifications are different between silk-
worm larvae and pupae.
BmNPV bacmid development and its applications
To construct a recombinant baculovirus containing a gene
of interest, cultured cells must be transfected with the
baculovirus and the transfer vector. Moreover, this system
requires the isolation and amplification of the recombinant
baculovirus. It takes a long time (3–6 months) to prepare
the high-titer recombinant baculovirus solution, and these
steps are very tedious and troublesome. A novel system for
the efficient production of recombinant AcMNPV was
reported, which is based on site-specific transposition in
Escherichia coli (Luckow et al. 1993). Luckow and
colleagues constructed a recombinant baculovirus vector
(bacmid) that can replicate in E. coli as a large plasmid.
This system is known as the Bac-to-Bac baculovirus
expression system, and various kits based on this Bac-to-
Bac system have been distributed from Invitrogen Corp.
This system reduces the time required to isolate and purify
a recombinant baculovirus and allows the simultaneous
construction of multiple recombinant baculoviruses.
Motohashi et al. (2005) constructed a BmNPV bacmid
and established the Bac-to-Bac system using BmNPV.
GFPuv was expressed with only the injection of BmNPV
bacmid DNA into silkworm larvae and pupae. This bacmid
system provided rapid expression of recombinant proteins,
since it did not require the preparation of a baculovirus
solution by transfection, as compared to the baculovirus
expression system using cultured cells (Fig. 1). Further-
more, this BmNPV bacmid system dramatically reduced the
time needed for recombinant protein production by silk-
worm expression.
Improved protein expression by a modified BmNPV
bacmid
Several proteins were produced using this BmNPV bacmid in
silkworm larvae (Yue et al. 2006; Zhang et al. 2008).
However, the degradation of recombinant proteins by
baculoviral cysteine protease also occurred (Park et al.
2007). Therefore, the BmNPV-CP
− bacmid was constructed,
and the GFPuv-β1,3-N-acetylglucosaminyltransferase2
(β3GnT2) fusion protein (GGT2) was expressed successful-
ly using this bacmid (Hiyoshi et al. 2007). The protease
activity in the hemolymph of silkworm larvae injected with
the BmNPV-CP
− bacmid was reduced by 85%, as compared
to that in the hemolymph of BmNPV-bacmid-injected
silkworm larvae. GGT2 degradation was also suppressed
by using the BmNPV-CP
− bacmid, and the β3GnT activity
was improved by 30%. Moreover, the β3GnT activity of
the hemolymph was improved 2.8-fold by using the
BmNPV-CP
−-Chi
− bacmid over that obtained with the
unmodified BmNPV bacmid (Park et al. 2008). Liquefac-
tion of larvae was delayed by using the BmNPV-CP
− and
BmNPV-CP
−-Chi
− bacmids (Fig. 2). The expression level
of human anti-bovine-serum-albumin (BSA) single-chain
Fv (scFv) fragment in hemolymph was 3.8–4.3-fold higher
with the BmNPV-CP
− or BmNPV-CP
−-Chi
− bacmid than
that with the unmodified BmNPV because of the suppres-
sion of degradation by the cysteine protease from BmNPV
(Fig. 2). However, no difference in the scFv expression
levels between the modified and unmodified bacmids was
observed in pupae (Ishikiriyama et al. 2009). This result
suggests that the baculoviral cysteine protease, v-cath, may
not be activated or only a small portion of the cysteine
protease may be expressed in pupae. Pupae may be useful
for the production of cysteine protease-sensitive proteins.
A hybrid nucleopolyhedrovirus (HyNPV) bacmid was
also constructed, by cotransfection with the AcMNPV
bacmid and pUC18/BmScH containing the BmScH frag-
ment of the DNA helicase gene from BmNPV (Deo et al.
2006). This bacmid allows baculoviral amplification in
AcMNPV and protein expression in BmNPV. To obtain a
high virus titer, this HyNPV bacmid is very helpful.
Molecular chaperones play an important role in protein
folding at the endoplasmic reticulum. Bacmids allow easy
coexpression of a chaperone with a target protein. The
expression level of a recombinant GFPuv-human α1,4-N-
acetylglucosaminyltransferase (α4GnT) fusion protein was
enhanced in silkworm larvae, by coexpression of a human
molecular chaperone, human calnexin (CNX), or immuno-
globulin heavy-chain binding protein (BiP; Nakajima et al.
2009). The expression of CNX and BiP under the control of
the polyhedrin promoter enhanced the α4GnTactivity by 1.4-
and 2.0-fold, respectively. When CNX or BiP under the
control of the ie-2 promoter was expressed during the early
stage of baculovirus infection, the α4GnT activity in the
hemolymph was also enhanced significantly. In silkworm
larvae, the coexpression of a chaperone with the target protein
effectively increases the quality of the recombinant protein.
Protein production using transgenic silkworms
Transgenic silkworms have also been used for recombinant
protein production. To establish transgenic silkworms, two
different systems, involving the use of an attenuated
recombinant baculovirus or a piggyBac transposon-derived
462 Appl Microbiol Biotechnol (2010) 85:459–470vector, were adopted (Tamura et al. 2000; Yamao et al.
1999). A method combining the two systems was also
established (Yamamoto et al. 2004). Human type III
procollagen and feline interferon were produced in cocoons
using transgenic silkworms (Kurihara et al. 2007; Tomita et
al. 2003). Human μ-opioid receptor was expressed in the
silk glands and fat bodies of transgenic silkworms, which
were screened by the GAL4/UAS system (Tateno et al.
2009). Its expression level was comparable to that obtained
in the baculovirus expression system using Sf-9 cells.
N-glycan structure produced by silkworm larvae
Insect cells can assemble N-glycan precursors to produce
high mannose or paucimannosidic end products. However,
the cells failed to elongate the trimmed N-glycan to produce
complex products containing terminal galactose and sialic
acid (SA) residues (Kost et al. 2005). Enzyme assays
revealed that the insect cell lines had little or none of the
galactosyltransferase and sialyltransferase activities in-
volved in N-glycan elongation.
When human anti-BSA IgG1 was expressed in hemo-
lymph, using the BmNPV-CP
−-Chi
− bacmid, its main N-
glycan structure was paucimannosidic (Park et al. 2009). In
accordance with this observation, human killer cell Ig-like
receptor 2DL1 was expressed using the BmNPV bacmid
(see details below), and the protein thus obtained harbored
the paucimannose-type oligosaccharides, Manalpha1-
6Manbeta1-4GlcNAcbeta1-4GlcNAc and Manalpha1-
6Manbeta1-4GlcNAcbeta1-4(Fucalpha1-6)GlcNAc (Sasaki
et al. 2009). However, the N-glycan of β3GnT2 purified
from the hemolymph of larvae contained terminal N-
acetylglucosamine (GlcNAcβ1,2Manα1,3(GlcNAcβ1,4)
(Manα1,6)Manβ1,4GlcNAcβ1,4GlcNA) and galactose
residues (Galβ1,4GlcNAcβ1,2Manα1,3(GlcNAcβ1,4)
(Manα1,6)Manβ1,4GlcNAcβ1,4GlcNAc), which were not
observed in samples from cultured cells (Dojima et al.
2009). These results indicate that β1,2N-acetylglucosami-
nyltransferase I (GlcNAcT I), β1,4N-galactosyltransferase
(GalT), and β1,4N-acetylglucosaminyltransferase III
(GlcNAcT III) might exist in silkworm larvae, but not in
insect cells (Fig. 3). Therefore, silkworm larvae would be
useful for the production of human glycoproteins, if the
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Fig. 1 Baculovirus gene expression system in insect cells and
silkworm larvae. a AcMNPV expression system using the AcMNPV
bacmid. The target gene was incorporated into the AcMNPV bacmid.
This extracted recombinant AcMNPV bacmid from E. coli was
transfected into insect cells. The resulting recombinant AcMNPV
was purified, amplified, and increased in titer and then was used for
insect cell infection. b Conventional BmNPV expression system. The
target gene and the wild-type BmNPV gene were cotransfected into B.
mori cells, and the recombinant BmNPV was obtained. This
recombinant BmNPV bacmid from E. coli was injected directly into
silkworm larvae. After 4–6 days postinjection, the recombinant
protein was harvested
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sialyltransferase.
Expression of glycosyltransferase in silkworm larvae
and its application to the synthesis of glycomimetics
to block infections by avian and human influenza viruses
Recently, the glycosyltransferase produced by silkworm
larvae was applied to the synthesis of sialoglycopolypeptides
for blocking influenza virus infection. Influenza viruses infect
host cells through the binding of viral hemagglutinins (HAs)
to sialoglycoproteins or sialoglycopeptides of the receptors on
thehostcellsurfaces(Suzukietal.1986). Since the molecular
recognition process leads to the adhesion of the host cells
and virus, molecules with a high affinity for the viral HA act
as potent inhibitors of infection by influenza viruses (Ogata
et al. 2007; Schengrund 2003). The host cell specificity of
the virus is dependent not only on the linkage of SAs to the
penultimate galactose but also on the number of SA residues
and the precise nature of the core structure (Gambaryan et al.
2004; Yamada et al. 2006). In order to synthesize an artificial
sialoglycoprotein, rat α2,6-sialyltransferase (ST6Gal I) was
expressed in fifth-instar silkworm larval hemolymph, using a
recombinant bacmid. Approximately 2.2 mg of ST6GalI was
purified from the hemolymph of 11 larvae. The substrate
specificity of the ST6GalI purified from hemolymph was the
same as that of the native rat ST6GalI. By using this
ST6GalI, the synthesis of a α2,6-sialoglycopolypeptide as a
glycoprotein mimetic was successfully achieved. The syn-
thesized α2,6-sialoglycopolypeptide selectively inhibited
hemagglutination induced by Sambucus nigra lectin, which
specifically binds to the Siaα2-6Gal(GalNAc) structure, and
showed approximately 780-fold higher affinity than fetuin as
a control (Ogataetal. 2009b). Moreover, Ogata et al. (2009a)
designed a series of γ-polyglutamic acid (γ-PGA)-based
glycopolypeptides carrying long/short R2,3/6 sialylated
glycans to act as inhibitors of the influenza virus. As an
alternative design, sialoglycopolypeptides carrying long-
spacer-linked glycans were engineered, by the replacement
of the N-acetyllactosamine (LN) unit by an alkyl chain. The
avian viruses specifically bound to glycopolypeptides carry-
ing a short sialoglycan with higher affinity than to a long
glycan. In contrast, human viruses preferentially bound not
only to a long R2,3/6 sialylated glycan with LN repeats in
the receptors but also to more spacer-linked glycans, in
which the inner sugar was replaced by a nonsugar structural
unit, such as a pentylamido group (Hidari et al. 2007). A
spaced tandem/triplet pentylamido repeat is a good mimetic
of a tandem/triplet LN repeat and thus provides a facile way
to design strong polymeric inhibitors of infection by avian
and human influenza viruses (Fig. 4).
Surface display system and subunit vaccine production
in silkworm
Baculovirus particles have become valuable tools in
biotechnology and medicine. Even a small virus provides
a huge surface, which can be engineered in many ways.
Heterologous peptides or proteins can be displayed on the
surface of baculovirus particles by fusing the peptide or
protein to the baculovirus surface glycoprotein, gp64
(Boublik et al. 1995). Baculoviruses displaying gp64
fusion proteins have proven to be very effective immu-
nogens (Kost et al. 2005). Since this approach was first
used to raise monoclonal antibodies against the nuclear
receptors LXRβ and FXR (Lindley et al. 2000), it has been
used for the development of low-cost insect larvae-derived
recombinant subunit vaccines. These include H5N1 influ-
enza vaccine (Jin et al. 2008), as well as subunit vaccines
against rabbit hemorrhagic disease virus (Pérez-Filgueira
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2005).
Recently, Li et al. (2008) reported that the capsid
proteins of foot-and-mouth disease virus (FMDV) were
produced in the hemolymph of silkworm larvae, and cattle
vaccinated with hemolymph, diluted 30-fold, were pro-
tected from challenge with FMDV.
The ability of BmNPV to display gp64 fusion proteins
also offers the possibility of using this silkworm as a host
for the production and display of a wide range of
antigenically important proteins on the cell or virus
surface. Using silkworm larvae, rather than insect cell
lines, as a host for recombinant virus amplification and
recombinant protein production has advantages, in terms of
their size and easiness to rear. The purified virus particles
displaying the cloned foreign protein on the viral envelope
could be used directly for functional analysis, without
isolating the proteins. Since the presence of the gp64
fusion protein did not alter the growth and yield of the
virus, the availability of the gp64-fusion-protein-displayed
virus will also provide insight into the virus–host cell
interaction, and this system may provide a fundamental
platform for large-scale vaccine production. The BmNPV-
based system is an economic process for the large-scale
production of surface-displayed baculoviruses and safe
subunit vaccines for animals, since the silkworm larvae,
which are easy to rear on a synthetic or natural diet, can be
used instead of the cultured cell lines.
Expression of pharmaceutically relevant proteins,
including cell/viral surface proteins
The infection of silkworms with recombinant BmNPV
virus is a very attractive strategy for protein production,
especially for cell surface receptors and secreted proteins,
which often require posttranslational modifications, includ-
ing sugar modifications. Silkworm expression is used for
the expression of pharmaceutically relevant proteins.
Immune cell and viral surface molecules and guanine
nucleotide-binding protein (G protein) coupled receptors
(GPCR) are the main drug targets because they regulate a
broad range of physiological functions (Kristiansen 2004).
The production of cell surface proteins using the silkworm-
BmNPV expression system is summarized in Table 2. The
expression levels ranged from several micrograms to
0.5 mg per larva. The proteins normally had signal
sequences and thus were secreted in the hemolymph when
properly processed. The obtained proteins were basically
functional, as confirmed by either ligand binding assays or
ELISA. Human killer cell immunoglobulin-like receptor,
KIR2DL1, which regulates natural killer cell function by
recognizing human leukocyte antigen C molecules, was
expressed successfully (Sasaki et al. 2009). The expression
level was high, 0.2 mg/larva, either by direct injection of
bacmid DNA or by injection of collected body fluid
containing the recombinant virus. Furthermore, the protein
was easily purified using Ni-NTA affinity chromatography.
Table 2 Expression of cell/viral surface proteins and GPCRs in silkworm
Receptor Gene transfer Yield Expression
level
Application Functional assay Function Reference
KIR2DL1 BmNPV Bacmid ~0.2 mg/
larva
SPR, sugar
characterization
Confirmed Sasaki
et al. 2009
IL4-Rα BmNPV 0.11 mg/ml
hemolymph
SPR, sugar
characterization
Confirmed Honjo
et al. 2008
IL4-Rα-Fc
a 0.053 mg/ml
hemolymph
Gel filtration
IL13-Rα1 0.55 mg/ml
hemolymph
IL13-Rα1-Fc
a 0.33 mg/ml
hemolymph
Influenza
hemagglutinin
BmNPV 0.4–4 μg/
larva
ELISA Not
confirmed
Sugiura
et al. 2001
Nociceptin
receptor (Giα1)
b
BmNPV bacmid Not
determined
[
35S]GTPγS binding assay
(EC50=9.3 ± 3.4 nM)
Kajikawa
et al. 2009
µ-Opioid
receptors
Transgenic 150–250 ng/
larva
[
3H]diprenorphine saturation
analysis (Kd=1.4~2.1 nM)
Tateno
et al. 2009
Expression of immune cell and viral surface receptors using silkworm
SPR surface plasmon resonance analysis
aFc fusion proteins
bGα-fusion proteins
466 Appl Microbiol Biotechnol (2010) 85:459–470The sugar modifications of the obtained KIR2DL1 protein
revealed that the protein harbored the relatively small
paucimannose-type oligosaccharides and thus seemed to
be appropriate for structural and binding studies of cell
surface receptors.
GPCRs are seven-transmembrane proteins and thus are
quite difficult to express due to their low solubility and
instability. The expression of a GPCR (human μ-opioid
receptor) in silkworms was first reported using a transgenic
technique, but the expression level was rather low, and
many technical steps were required (Tateno et al. 2009).
The expression of other GPCRs using other expression
systems including Sf9 and CHO cells was reviewed by
Massotte (2003) and Sarramegna et al. (2003). Human
GPCR (human nociceptin receptor) expression was
reported recently by the simple injection of BmNPV
bacmid DNA into the silkworm (Kajikawa et al. 2009).
Human nociceptin receptor, which is an inhibitory GPCR
for an exogenous opioid peptide, nociceptin, involved in
pain control ( Meunier 1997), was actually produced as a
membrane protein in microsomal fractions of the fat bodies
of silkworms. The microsomal fractions including func-
tional GPCRs could be very easily prepared by a simple
operation and centrifugation. Interestingly, the protein was
also expressed in the BmNPV viral fraction, which was
consistent with that previously reported for the GPCR
expression in Sf9 cells (Masuda et al. 2003). GPCRs
physiologically bind at the cytoplasmic region to a trimeric
G protein, composed of alpha (Gα), beta (Gβ), and gamma
(Gγ) subunits (Wess 1997). The ligand binding to GPCRs
enhances the guanosine triphosphatase (GTPase) activity
of the trimeric G protein, resulting in its dissociation
from GPCRs by exchanging Gα-bound GTP to GDP,
which triggers the G-protein-mediated signal transduction
(Liebmann and Bohmer 2000). The nociceptin receptor
fused with the G protein alpha subunit (Giα), whose ligand
recognition can be detected by measuring the [
35S]GTPγS
binding, was also successfully expressed in the same system
as the nonfused protein as described above. This expression
system exhibited sufficient production for 500 binding
assays using the radiolabeled compound, [
35 S]GTPγS.
The expression level of the nonfusion type of nociceptin
receptor was much higher than that of the fusion type.
Silkworms also have the capacity to produce functional
membrane proteins in the same way as secretory proteins.
Many membrane proteins have been produced in the
hemolymph and pupae of silkworms as secretory proteins.
Recently, human (pro)renin receptor (hPRR) and its
complex with human prorenin were expressed in silkworm
larvae, with the same expression level as some secretory
proteins, and were purified from the fat bodies of larvae
(Du et al. 2008, 2009a). This hPRR may be helpful for the
development of an hPRR blocker.
Conclusions and future developments
The BmNPV bacmid system is innovative and easy to
use for producing large amount of recombinant protein,
without any laborious techniques. Many BmNPV DNAs
for recombinant protein expression can be constructed
r a p i d l yb yt h eB m N P Vb a c m i ds y s t e m ,b a s e do nt h e
Bac-to-Bac system. Moreover, expression of multi-
subunit complexes can be achieved simply by injection
of a mixture of BmNPV bacmids into silkworms, without
prior virus amplification using cultured cells. The protein
expression levels in bacmid-injected silkworm larvae are
very high, which reduces the cost of large-scale produc-
tion. This BmNPV bacmid-silkworm expression strategy
is very successful for expression of membrane proteins
including GPCRs which are major drug targets. There-
fore, this system is very promising and will be useful for
high-throughput drug screening of many transmembrane
proteins and orphan GPCRs for which physiological
ligands have not yet been identified (Takeda et al. 2002;
Wise et al. 2004).
In Asian countries, silkworms are abundantly available,
and many laboratories have experience in rearing and
maintaining larvae. Thus, the opportunity to utilize the
long-forgotten resourceful silkworm for producing thera-
peutically important proteins, vaccines, and biomaterials is
here. By the spurt in influenza viruses, vaccines for
influenza viruses are being actively produced in insect cell
system. More and more patents are being procured for
customized insect cell lines and their products are making
inroads into the market which until now had been
dominated by other production systems. With the genomic
elucidation of silkworm, even more laboratories around the
world will be interested in its utilization. We expect that the
glory of silkworm is returning back, and it will be once
more associated with wealth and prosperity.
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